Filing Details
- Accession Number:
- 0001079973-20-000534
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-06-22 16:40:28
- Reporting Period:
- 2020-06-18
- Accepted Time:
- 2020-06-22 16:40:28
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
885074 | Aeon Global Health Corp. | AGHC | Services-Medical Laboratories (8071) | 141673067 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1232118 | Lllp Fund Microcap Ibex | 260 N. Josephine Street, Suite 300 Denver CO 80206 | No | No | Yes | No | |
1531960 | B Justin Borus | 260 N. Josephine Street, Suite 300 Denver CO 80206 | No | No | Yes | No | |
1531964 | Ibex Investors Llc | 260 N. Josephine Street, Suite 300 Denver CO 80206 | No | No | Yes | No | |
1639757 | Lllp Partners Micro Macro Lazarus | 260 N. Josephine Street, Suite 300 Denver CO 80206 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2020-06-18 | 9,889 | $0.07 | 448,244 | No | 4 | S | Indirect | By: Ibex Microcap Fund LLLP |
Common Stock | Disposition | 2020-06-18 | 184,000 | $0.06 | 264,244 | No | 4 | S | Indirect | By: Ibex Microcap Fund LLLP |
Common Stock | Disposition | 2020-06-18 | 23,129 | $0.06 | 241,115 | No | 4 | S | Indirect | By: Ibex Microcap Fund LLLP |
Common Stock | Disposition | 2020-06-18 | 46,871 | $0.06 | 194,244 | No | 4 | S | Indirect | By: Ibex Microcap Fund LLLP |
Common Stock | Disposition | 2020-06-19 | 5,000 | $0.07 | 189,244 | No | 4 | S | Indirect | By: Ibex Microcap Fund LLLP |
Common Stock | Disposition | 2020-06-19 | 2,500 | $0.07 | 186,744 | No | 4 | S | Indirect | By: Ibex Microcap Fund LLLP |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | By: Ibex Microcap Fund LLLP |
No | 4 | S | Indirect | By: Ibex Microcap Fund LLLP |
No | 4 | S | Indirect | By: Ibex Microcap Fund LLLP |
No | 4 | S | Indirect | By: Ibex Microcap Fund LLLP |
No | 4 | S | Indirect | By: Ibex Microcap Fund LLLP |
No | 4 | S | Indirect | By: Ibex Microcap Fund LLLP |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 833 | Indirect | By: Lazarus Macro Micro Partners LLLP |
Footnotes
- These securities reported herein are owned directly by Ibex Microcap Fund LLLP ("Ibex Microcap"). Ibex Investors LLC ("Ibex") is the investment adviser and general partner of Ibex Microcap and Justin B. Borus is the manager of Ibex.
- These securities reported herein are owned directly by Lazarus Macro Micro Partners LLLP ("Macro Micro"). Ibex is the investment adviser and general partner of Macro Micro.
- Each of Ibex and Mr. Borus expressly disclaims beneficial ownership of the securities held by Ibex Microcap and Macro Micro (referred to collectively as the "Funds") except to the extent of his or its pecuniary interest therein, if any. Each of the Funds expressly disclaims beneficial ownership of the securities held by the other Fund. The filing of this Form 4 shall not be construed as an admission that either Ibex or Mr. Borus (or each Fund with respect to the securities held by the other Fund), for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, is the beneficial owner of any of the securities reported herein.
- Includes 5,159 shares of Common Stock issued to Ibex Microcap as dividends on the Series D Convertible Preferred Stock through and including the dividend payment date of December 31, 2018, which acquisition was exempt from the reporting requirements of Section 16 of the Securities Exchange Act of 1934.